Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.30 (-0.46%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.40m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Trading Update

10 Jul 2025 07:00

RNS Number : 4389Q
Macfarlane Group PLC
10 July 2025
 

 

10 July 2025

Macfarlane Group PLC

("Macfarlane" or the "Group")

Trading update

Reduction in full year expectations

Macfarlane Group PLC is updating the market today in advance of its 2025 interim results due to be released on 28 August 2025.

· In a year of challenge and economic uncertainty, we currently expect full year 2025 Adjusted Operating Profit1 to be approximately 10% below 2024.

· Distribution is experiencing weaker than expected demand, delays in new business decision making, pressure on gross margin due to the competitive environment, rising input prices and slower than anticipated recovery of labour and property-related cost increases.

· Manufacturing Operations is performing robustly with good momentum with our aerospace and defence related customers and the benefit of the Polyformes acquisition, marginally offset by the slowdown in those sectors where customers are being impacted by uncertainty over US tariffs.

· We expect the Pitreavie business, acquired in January, to benefit from the normal seasonal uplift in demand in H2 2025, together with additional sales from in-house supply to Macfarlane Distribution.

· The focus for the remainder of 2025 is the recovery of cost increases, the implementation of additional cost saving actions and ensuring we convert the strong new business pipeline.

· Net bank debt remains well within the Group's £40m facility.

· The recently launched share buyback programme will continue as planned.

Commenting on today's announcement Aleen Gulvanessian, Chair of the Group, said:

"We highlighted in our AGM statement that market conditions in 2025 were challenging. It is disappointing that the momentum increase we experienced early in Q2 2025 has not been maintained and as a result will impact our full year performance.

Management is focused on implementing an action plan to recover cost increases and execute against our strong pipeline of new business.

The Board remains confident that our strengthened sales team, differentiated customer proposition and proven executional skills mean that the prospects for the Group remain positive.

​We will provide a further update along with the announcement of our interim results on 28 August 2025."

 

1Operating profit before amortisation and deferred contingent consideration adjustments

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Aleen Gulvanessian Chair

Peter Atkinson Chief Executive

Ivor Gray Finance Director

 

Spreng Thomson

Callum Spreng

Mob: 07803 970103

Legal Entity Identifier (LEI): 213800LVRYDERSJAAZ73

Notes to Editors:

· Macfarlane Group PLC has been listed on the Main Market of the London Stock Exchange plc (LSE: MACF) since 1973, with over 70 years' experience in the UK packaging industry.

· Through its two divisions, Macfarlane Group services a broad range of business customers, supplying them with high-quality protective packaging products which help customers reduce supply chain costs, improve operational efficiencies and sustainability and enhance their brand presentation. The divisions are:

Packaging Distribution - Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and

Manufacturing Operations - Macfarlane Design and Manufacture is a UK market leader in the design and production of protective packaging for high value and fragile products.

· Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,000 people at 43 sites, principally in the UK, as well as in Ireland, Germany and the Netherlands.

· Macfarlane Group supplies more than 20,000 customers, principally in the UK and Europe.

· In partnership with 1,700 suppliers, Macfarlane Group distributes and manufactures 600,000+ lines, supplying to a wide range of sectors, including: retail e-commerce; consumer goods; food; logistics; mail order; electronics; defence; medical; automotive; and aerospace.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFERDIIAIIE
Date   Source Headline
2nd Oct 20237:00 amRNSAcquisition of B&D 2010 Group Limited
29th Aug 20237:00 amRNSIssue of Shares
24th Aug 20237:00 amRNSHalf-year Report
8th Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
4th Aug 20237:00 amRNSNotice of Results
6th Jul 20231:29 pmRNSHolding(s) in Company
9th May 20233:08 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Trading Update
2nd May 20237:00 amRNSAcquisition
28th Apr 20235:17 pmRNSNotice of AGM
20th Apr 20235:18 pmRNSHolding(s) in Company
20th Apr 20232:03 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSAnnual Report 2022
27th Mar 202312:29 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSAcquisition
23rd Feb 20237:00 amRNSAnnual Results 2022
15th Feb 20237:00 amRNSNotice of Results
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Nov 20227:00 amRNSDirector/PDMR Shareholding
24th Nov 20227:00 amRNSTrading Update
7th Oct 202210:00 amRNSHolding(s) in Company
7th Oct 202210:00 amRNSHolding(s) in Company
27th Sep 20221:57 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSAppointment of Non-Executive Director
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
25th Aug 20227:16 amRNSHalf-year Report
5th Aug 20227:00 amRNSNotice of Results
19th May 20227:00 amRNSDirector/PDMR Shareholding
17th May 202212:00 pmRNSAcquisition
16th May 20227:00 amRNSIssue of Shares
10th May 20223:24 pmRNSResult of AGM
10th May 202212:00 pmRNSTrading Update
6th Apr 20227:00 amRNSNotice of AGM
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSAnnual Report 2021
25th Mar 20224:12 pmRNSDirector/PDMR Shareholding
11th Mar 20223:41 pmRNSDirector/PDMR Shareholding
24th Feb 20221:00 pmRNSDividend Payment Date
24th Feb 20227:00 amRNSFinal Results
11th Feb 20227:00 amRNSNotice of Results
4th Jan 20227:00 amRNSDisposal
25th Nov 20217:00 amRNSTrading Update
18th Nov 202110:17 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
6th Aug 20217:00 amRNSNotice of Interim Results
25th Jun 20214:41 pmRNSSecond Price Monitoring Extn
25th Jun 20214:36 pmRNSPrice Monitoring Extension
12th May 20217:00 amRNSResult of AGM
11th May 202112:00 pmRNSBoard Changes
11th May 202112:00 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.